Early Gastrointestinal Cancers, 2012 Recent Results in Cancer Research Series, Vol. 196
Coordonnateurs : Otto Florian, Lutz Manfred P.
Clinically relevant study end points in rectal cancer.- Neoadjuvant treatment in rectal cancer: Do we always need radiotherapy?- Treatment dilemmas in patients with synchronous colorectal liver metastases.- Pancreatic surgery: beyond the traditional limits.- Adjuvant therapy for pancreatic cancer.- Radiotherapy of the pancreas: state of the art in 2012.- Adenocarcinoma of the GEJ: gastric or oesophageal cancer?- Why is there a change in patterns of GE cancer?- Open or minimally invasive resection for oesophageal cancer?- Criteria for selecting the best multimodal therapy.- When is the definitive radiochemotherapy the treatment of choice?- Radiotherapy of gastroesophageal junction (GEJ) cancer.- Optimizing neoadjuvant chemotherapy through the use of early response evaluation by PET .- Optimal surgery for gastric cancer: is more always better?- Can adjuvant chemoradiotherapy replace extended lymph node dissection in gastric cancer?- Predicting the response to chemotherapy in gastric adenocarcinoma: who benefits from neoadjuvant chemotherapy?- Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.- Selecting the best treatment for an individual patient.
Up-to-date recommendations on the diagnosis and treatment of early gastrointestinal malignancies from some of the world’s leading experts
Highlights areas of consensus and controversy in the care of patients with cancer of the gastrointestinal tract
Of value for every clinician involved in the care of patients with gastrointestinal malignancies ?
Includes supplementary material: sn.pub/extras
Includes supplementary material: sn.pub/extras
Date de parution : 12-2014
Ouvrage de 320 p.
15.5x23.5 cm
Date de parution : 11-2012
Ouvrage de 320 p.
15.5x23.5 cm